Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides

Details for Australian Patent Application No. 2007311395 (hide)

Owner Oncotherapy Science, Inc.

Inventors Nakamura, Yusuke; Tsunoda, Takuya; Fujioka, Tomoaki; Shida, Midori; Osawa, Ryuji

Agent Davies Collison Cave

Pub. Number AU-A-2007311395

PCT Pub. Number WO2008/047473

Priority 60/852,575 17.10.06 US

Filing date 16 October 2007

Wipo publication date 24 April 2008

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/047473 Priority application(s): WO2008/047473

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007311398-An image guided whole body stereotactic needle placement device

2007311340-Power conversion device